Literature summary extracted from
Danley, D.E.; Baima, E.T.; Mansour, M.; Fennell, K.F.; Chrunyk, B.A.; Mueller, J.P.; Liu, S.; Qiu, X.
Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase (2015), Protein Sci., 24, 20-26.
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
2.5.1.31 |
gene uppS, recombinant His-tagged enzyme expression in Escherichia coli strain BL21 |
Streptococcus pneumoniae |
Crystallization (Commentary)
EC Number |
Crystallization (Comment) |
Organism |
---|
2.5.1.31 |
purified recombinant enzyme free or in complex with substrate (2E,6E)-farnesyl diphosphate, X-ray diffraction structure determination and analysis at resolutions of 2.2 A and 2.1A, respectively |
Streptococcus pneumoniae |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
2.5.1.31 |
3-(2-chlorophenyl)-N-(4-isopropylphenyl-5-methylisoxazole-4-carboxamide) |
i.e. UK-106051, a drug-like UPPs inhibitor, UK-106051 binds to a site in the middle of this binding cleft. Substrates FPP and IPP cannot bind simultaneously to UPPs-inhibitor binary complexes |
Streptococcus pneumoniae |
|
Metals/Ions
EC Number |
Metals/Ions |
Comment |
Organism |
Structure |
---|
2.5.1.31 |
Mg2+ |
required |
Streptococcus pneumoniae |
|
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
2.5.1.31 |
(2E,6E)-farnesyl diphosphate + 8 isopentenyl diphosphate |
Streptococcus pneumoniae |
- |
8 diphosphate + ditrans,octacis-undecaprenyl diphosphate |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
2.5.1.31 |
Streptococcus pneumoniae |
Q8DRB3 |
- |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
2.5.1.31 |
recombinant His-tagged enzyme from Escherichia coli strain BL21 by nickel affinity chromatography and gel filtration |
Streptococcus pneumoniae |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
2.5.1.31 |
(2E,6E)-farnesyl diphosphate + 8 isopentenyl diphosphate |
- |
Streptococcus pneumoniae |
8 diphosphate + ditrans,octacis-undecaprenyl diphosphate |
- |
? |
|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
2.5.1.31 |
undecaprenyl pyrophosphate synthase |
- |
Streptococcus pneumoniae |
2.5.1.31 |
UPPs |
- |
Streptococcus pneumoniae |
Temperature Optimum [°C]
EC Number |
Temperature Optimum [°C] |
Temperature Optimum Maximum [°C] |
Comment |
Organism |
---|
2.5.1.31 |
37 |
- |
assay at |
Streptococcus pneumoniae |
pH Optimum
EC Number |
pH Optimum Minimum |
pH Optimum Maximum |
Comment |
Organism |
---|
2.5.1.31 |
7.5 |
- |
assay at |
Streptococcus pneumoniae |
IC50 Value
EC Number |
IC50 Value |
IC50 Value Maximum |
Comment |
Organism |
Inhibitor |
Structure |
---|
2.5.1.31 |
0.00005 |
- |
pH 7.5, 37°C |
Streptococcus pneumoniae |
3-(2-chlorophenyl)-N-(4-isopropylphenyl-5-methylisoxazole-4-carboxamide) |
|
General Information
EC Number |
General Information |
Comment |
Organism |
---|
2.5.1.31 |
physiological function |
the enzyme is an essential enzyme in a key bacterial cell wall synthesis pathway. It catalyzes the consecutive condensations of isopentenyl diphosphate groups on to a trans-farnesyl diphosphate to produce the C55 isoprenoid undecaprenyl diphosphate |
Streptococcus pneumoniae |